Allergan PLC (2015) Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Dublin Ireland (2015)
Status: Acquired by AbbVie (2019)

Organization Overview

First Clinical Trial
2015
NCT00487578
First Marketed Drug
2015
pancrelipase (creon)
First NDA Approval
2018
sarecycline hydrochloride (seysara)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Allergan, plc | Cady, Roger, M.D. | DBYAN Medicine Professional Corporation | Forest Laboratories, an Allergan affiliate | Roger Cady, M.D. | TransDerm, Inc. | VIOKACE | Vitae Pharmaceuticals Inc., an Allergan affiliate